Epstein-Barr virus infections and their association with human malignancies: Some key questions

Annals of Medicine

Volumn 30, Issue 3, 1998, Pages 249-259

  Griffin, Beverly E ^a,b   Xue, Shao An ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Burkitt's lymphoma; Cancer; Cofactors; Epstein Barr virus; Immortalizing regions; Immune escape; Oncogenes; Viral variants; Virus receptors; Virus reservoir

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 10;

B LYMPHOCYTE; BURKITT LYMPHOMA; CELL DIVISION; CELL GROWTH; DNA TUMOR VIRUS; EPITHELIUM; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNE SYSTEM; MALIGNANT NEOPLASTIC DISEASE; NASOPHARYNX CARCINOMA; ONCOGENE C MYC; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS GENE; VIRUS INFECTION;

EID: 0031747314     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899809005852     Document Type: Review

References (23)

1. Rickinson AB, Kieff E. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields Virology. 3rd edn. Philadelphia, PA: Lippincott - Raven Publishers; 1996: 2397-437.
2. Barel M, Balbo M, Gauffre A, Frade R. Binding sites of the Epstein-Barr virus and C3d receptor (CR2, CD21) for its three intracellular ligands, the p53 anti-oncoprotein, the p68 calcium binding protein and the nuclear p120 ribonucleoprotein. Mol Immunol 1995; 32: 389-97.
3. Knox PG, Li QX, Rickinson AB, Young LS. In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma. Virology 1996; 215: 40-50.
4. Tsoukas CD, Lambris, JD. Expression of EBV/C3d receptors on T cells: biological significance. Immunol Today 1993; 14: 56-9.
5. Yoshiyama H, Imai S, Shimizu N, Takada K. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol 1997; 71: 5688-91.
6. Gratama JW, Oosterveer MAP, Zwaan FE, Lepoutre J, Klein G, Ernberg I. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for the site of viral latency. Proc Natl Acad Sci USA 1988; 85: 8693-7.
7. Gratama JW Lennette ET, Lönnqvist B, et al. Detection of multiple Epstein-Barr viral strains in allogeneic bone marrow transplant recipients. J Med Virol 1992; 37: 39-47.
8. Allday, MJ, Crawford DH. Role of epithelium in EBV persistence and pathogenesis of B-cell tumours. Lancet 1988; 1: 855-7.
9. Bayliss GH, Wolf H. An Epstein-Barr virus early protein induces cell fusion. Proc Natl Acad Sci U S A 1981; 3: 7162-5.
10. Miyashita EM, Yang B, Lam KMC, Grawford DH, Thorley-Dawson DA. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 1995; 80: 593-601.
11. Dimitrov DS. How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity. Cell 1997; 91: 721-30.
12. Kieff E. Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields Virology. 3rd edn. Philadelphia, PA: Lippincott - Raven Publishers; 1996: 2343-96.
13. Baer R, Bankier AT, Biggin MD, et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984; 310: 207-11.
14. Knecht H, Bachmann E, Brousett P, et al. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993; 82: 2937-42.
15. Khan G, Naase MA. Down-regulation of Epstein-Barr virus nuclear antigen 1 in Reed-Sternberg cells of Hodgkin's disease. J Clin Pathol 1995; 48: 845-8.
16. Kempkes B, Pich D, Zeidler R, Sugden B, Hammerschmidt W. Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA. J Virol 1995; 69: 231-8.
17. Robertson E, Kieff E. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs. J Virol 1995; 69: 983-93.
18. Griffin BE, Karran L. Immortalization of monkey epithelial cells by specific fragments of Epstein-Barr virus DNA. Nature 1984; 309: 78-82.
19. Karran L, Teo CG, King D, et al. Establishment of immortalized primate epithelial cells with sub-genomic EBV DNA. Int J Cancer 1990; 45: 763-72.
20. Hitt MM, Allday MJ, Hara T, et al. EBV gene expression in an NPC-related tumour. EMBO J 1989; 8: 2639-51.
21. Wei MX, Ooka T. A transforming function of the BARF1 gene encoded by Epstein-Barr virus. EMBO J 1989; 8: 2897-903.
22. van Gorp J, Brink A, Oudejans JJ, et al. Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas. J Clin Pathol 1996; 49: 72-6.
23. Wen S, Mizugaki Y, Shinozaki, Takada K. Epstein-Barr virus (EBV) infection in salivary gland tumors: lytic EBV infection in nonmalignant epithelial cells surrounded by EBV-positive T-lymphoma cells. Virology 1997; 227: 72-6.